Drug Shortage Report for LOSARTAN/HCTZ
Report ID | 82941 |
Drug Identification Number | 02427664 |
Brand name | LOSARTAN/HCTZ |
Common or Proper name | LOSARTAN/HTZ |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 25MG 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-06-03 |
Actual start date | |
Estimated end date | |
Actual end date | 2021-05-05 |
Shortage status | Resolved |
Updated date | 2021-05-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-05-06 | English | Compare |
v5 | 2021-05-05 | French | Compare |
v4 | 2021-05-05 | English | Compare |
v3 | 2019-06-04 | English | Compare |
v2 | 2019-05-01 | French | Compare |
v1 | 2019-05-01 | English | Compare |
Showing 1 to 6 of 6